Identify the concern
Understand how staff recognize and raise AI-related concerns. Agree on the signals and context worth capturing.
Identify, review, and respond to AI-related safety risks across clinical workflows. Help shape the next layer of oversight.
Skovos PSO: In development.
Membership will be available only after AHRQ listing.
Today's conversation is exploratory.
A proposed view of AI-related safety concerns.
| Event | Agent | Clinical area | Severity | Status | Last activity |
|---|---|---|---|---|---|
| Inappropriate treatment recommendation | Care Summary Agent | Oncology | Critical | Escalated | 12 min ago |
| Contraindicated medication suggested | Clinical Decision Agent | Cardiology | High | Under review | 28 min ago |
| Missing key differential diagnosis | Triage Agent | Emergency | Medium | In progress | 1 hour ago |
| Unsupported lab result | Note Generation Agent | Internal Medicine | High | Escalated | 2 hours ago |
| Unsafe discharge advice | Patient Outreach Agent | Primary Care | Medium | Reviewed | 3 hours ago |
Explore ways to flag potentially harmful AI outputs and behaviors.
Define who reviews each concern and how the right team gets involved.
Design a clear record of the review, decisions, and follow-up actions.
A workflow to shape together
Start with one clinical workflow and the people responsible for it. Together, we can map where AI is involved, what needs review, and how a response should move forward.
Understand how staff recognize and raise AI-related concerns. Agree on the signals and context worth capturing.
Bring the right clinical, quality, and risk teams into the review. Clarify the agent's role and the human decisions around it.
Define who owns the response, which controls are possible on supported connections, and how changes will be followed.
Help shape what comes next
We are inviting potential founding partners to help shape the initiative. Bring a process description or a de-identified example. We will discuss a potential engagement with agreed scope, responsibilities, and deliverables.
Discuss a founding partnership